StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) KPIs and segments

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive ALX Oncology's business

Coming soon

This tab will track the numbers specific to ALX Oncology's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?